Urgent surgery vs fibrinolytic therapy for left-sided prosthetic valve thrombosis: a randomized trial.
European heart journal, 2025 · Single-center randomized trial
What the trial found
No significant response difference, OR 1.22 (0.46–3.19). Safety composite more frequent with surgery, OR 5.14 (1.28–20.5); 25% lysis residual dysfunction.
Clinical interpretation
Single-center expertise, wide intervals and residual dysfunction constrain universal treatment choices.